Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2021 / Jul / Developing Digitally
Digital and computational pathology Digital Pathology

Developing Digitally

Talat Zehra highlights the need for universal access to digital and telepathology

By Talat Zehra 07/13/2021 Quick Read (pre 2022) 1 min read

Share

I’d like to share a story from my personal experience that highlights the benefits of telepathology by illustrating how its absence negatively impacted a patient’s care.

A while ago, a case reached us from a remote area four days after the surgical removal of an axillary mass from a 13-year-old boy. By the time we received the sample, it was improperly fixed. We changed the formalin immediately and then processed it – but, when we got the slides, it came out as partly autolyzed Hodgkin lymphoma. We had to provide a guarded opinion, so we advised marker studies (even though marker studies will not usually give adequate results in an inadequately fixed specimen). It’s well known that Hodgkin lymphoma, if diagnosed in a timely manner, is associated with excellent outcomes, because it is a highly radiosensitive tumor. Now imagine the frustration of the patient, the clinician, and the pathologist – all caused by issues that could be easily addressed with digital pathology!

These issues are still common in developing parts of the world due to the scarcity of pathologists and labs in rural areas, which often house the majority of the population. Delayed diagnosis is associated with increased patient morbidity and mortality. My key message? This story is not a one-off. Pathologists working in developing regions have many such tales – but, the more we can increase access to digital pathology, the less often we may hear them in future.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Talat Zehra

Talat Zehra is Assistant Professor and consultant histopathologist at Jinnah Sind Medical University, Karachi, Pakistan.

More Articles by Talat Zehra

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Global Referral
Digital and computational pathology
Global Referral

January 12, 2024

10 min read

How digital pathology is transforming the delivery of remote second opinions

Cracking Colon Cancer
Digital and computational pathology
Cracking Colon Cancer

January 25, 2024

1 min read

How a new clinically approved AI-based tool enables rapid microsatellite instability detection

The (Pathology) IT Crowd?
Digital and computational pathology
The (Pathology) IT Crowd?

December 30, 2021

5 min read

The pathologist’s guide to IT considerations for digitization

Defining the Next Generation of NGS
Digital and computational pathology
Defining the Next Generation of NGS

December 31, 2021

1 min read

Overcoming challenges of the typical NGS workflow with the Ion Torrent™ Genexus™ System

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.